维普中文期刊产品整合服务
172篇 您的检索式:作者名="Blajchman"
    题名 作者 年代 出处 被引量
1A mul ticenter,ranodomized,controlled clinical trial oftransfusion requirements in critical care显示文摘H6bert PC WellS G Blajchman MA 1999N Engl J Med1999,340,6:1
2Transfusion-associated immunomdulation and universal white celJ reduction :are we putting the cart before the horse显示文摘Blajchman MA 1999Transfusion1999,39,7:1
3Transfusion-related mortality:the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention显示文摘Vamvakas EC Blajchman MA 2009Blood2009,113,15:1
4Transfusion related mortality: the on- going risks of allogeneic blood transfusion and the available strategies for their prevention显示文摘Vamvakas EC Blajchman MA 2009Blood2009,15,:1
5The clinical benefits of the leukoreduction of blood products 显示文摘Blajchman MA 2006J Trauma Inj Infect Crit Care2006,60,6:1
6A multicenter,randomized controlled clinical trial of transfusion require-ments in critical care:Transfusion Requirements in Criti-cal Care Investigators,Canadian Critical Care TrialsGroup显示文摘Hebert PC Well G Blajchman CN 1999N Engl J Med1999,340,:1
7Novel platelet products ,substitutes and alternatives 显示文摘Blajchman MA 2001Transfus Clin Biol2001,8,3:1
8Bacterial contamination of blood products显示文摘Blajchman MA 2001Transfus Apher Sci2001,24,3:1
9Why implement universal leukoreduction显示文摘Bassuni WY Blajchman MA Al-Moshary MA 0,,02:1
10Transfusion-related acute lung injury 显示文摘Webert KE Blajchman MA 2005Curt Opin Hematol2005,12,6:1
11New strategies for the optimal use of platelet transfusions显示文摘Blajchman MA Slichter SJ Heddle NM 2008Hematology Am Soc Hematol Educ Program2008,2008,1:1
12Transfusion-related acute lung injury显示文摘Webert KE Blajchman MA 2005Curr Opin Hematol2005,12,:1
13Improving the bacteriological safety of platelet transfusions显示文摘Blajchman MA Goldman M Baeza F 2004Transfus Med Rev2004,18,1:1
14Transfusion - related acute lung injury显示文摘Webert KE Blajchman MA 2003Transfus Med Rev2003,17,:1
15Immunomomodulatory effects of allogeneic blood transfusions:clinical manifestation and mechanisms显示文摘Blajchman US 1998Vox Sang1998,74,2:1
16Transfusion requirements in critical careinvestigators, Canadian critical care groups 显示文摘Hebert PC Wells G Blajchman MA 1999N Engl J Med1999,340,6:1
17Immtmomodulation and blood transfusion 显示文摘Blajchman MA 2002Am J Ther2002,9,5:1
18Improving the bacteriological safety of platelet transfusion显示文摘Blajchman MA Goldman M Baeza F 2004Transfus Med Rev2004,18,1:1
19A multicenter,randomized,controlled climical trial of transfusion requirements in critical care显示文摘Hebert PC Wells G Blajchman MA 1999N Engl J Med1999,340,6:1
20Improving the bacteriological safety of platelet transfusions 显示文摘Blajchman MA Goldman M Baeza F 2004Transfus Med Rev2004,18,1:1
返回顶部 每页显示:
共9页 首页 上一页 第1页 下一页 末页 /9 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费